Metformin-induced thyrotropin suppression is not associated with cardiac effects

Carlo Cappelli, Mario Rotondi, Ilenia Pirola, Barbara Agosti, Ana Maria Formenti, Pasquale De Cata, Massimo Salvetti, Luca Chiovato, Maurizio Castellano

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p

Original languageEnglish
Pages (from-to)252-258
Number of pages7
JournalHormones
Volume13
Issue number2
Publication statusPublished - 2014

Fingerprint

Metformin
Thyrotropin
Hyperthyroidism
Thyroid Diseases
Serum
Thyroxine
Therapeutics
Heart Rate

Keywords

  • Atrial fibrillation
  • Metformin
  • Sub-clinical hyperthyroidism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Cappelli, C., Rotondi, M., Pirola, I., Agosti, B., Formenti, A. M., De Cata, P., ... Castellano, M. (2014). Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones, 13(2), 252-258.

Metformin-induced thyrotropin suppression is not associated with cardiac effects. / Cappelli, Carlo; Rotondi, Mario; Pirola, Ilenia; Agosti, Barbara; Formenti, Ana Maria; De Cata, Pasquale; Salvetti, Massimo; Chiovato, Luca; Castellano, Maurizio.

In: Hormones, Vol. 13, No. 2, 2014, p. 252-258.

Research output: Contribution to journalArticle

Cappelli, C, Rotondi, M, Pirola, I, Agosti, B, Formenti, AM, De Cata, P, Salvetti, M, Chiovato, L & Castellano, M 2014, 'Metformin-induced thyrotropin suppression is not associated with cardiac effects', Hormones, vol. 13, no. 2, pp. 252-258.
Cappelli C, Rotondi M, Pirola I, Agosti B, Formenti AM, De Cata P et al. Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones. 2014;13(2):252-258.
Cappelli, Carlo ; Rotondi, Mario ; Pirola, Ilenia ; Agosti, Barbara ; Formenti, Ana Maria ; De Cata, Pasquale ; Salvetti, Massimo ; Chiovato, Luca ; Castellano, Maurizio. / Metformin-induced thyrotropin suppression is not associated with cardiac effects. In: Hormones. 2014 ; Vol. 13, No. 2. pp. 252-258.
@article{42c1c4d713cf4d69a8d2d2eec958dded,
title = "Metformin-induced thyrotropin suppression is not associated with cardiac effects",
abstract = "Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p",
keywords = "Atrial fibrillation, Metformin, Sub-clinical hyperthyroidism",
author = "Carlo Cappelli and Mario Rotondi and Ilenia Pirola and Barbara Agosti and Formenti, {Ana Maria} and {De Cata}, Pasquale and Massimo Salvetti and Luca Chiovato and Maurizio Castellano",
year = "2014",
language = "English",
volume = "13",
pages = "252--258",
journal = "Hormones",
issn = "1109-3099",
publisher = "Hellenic Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Metformin-induced thyrotropin suppression is not associated with cardiac effects

AU - Cappelli, Carlo

AU - Rotondi, Mario

AU - Pirola, Ilenia

AU - Agosti, Barbara

AU - Formenti, Ana Maria

AU - De Cata, Pasquale

AU - Salvetti, Massimo

AU - Chiovato, Luca

AU - Castellano, Maurizio

PY - 2014

Y1 - 2014

N2 - Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p

AB - Objective: Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine. Design: Heart rate, P wave duration, P wave dispersion, QTmax, QTmin and QT-dispersion were assessed in 23 patients with diabetes treated with metformin before and after 6 months of TS H-suppression and in 31 control patients with SHT. Results: No significant changes in electrocardiographic parameters were observed from baseline to the TSH-suppression measurement. A significant difference in P wave duration (102.9±7.4 vs. 92.1±5.8 ms, p

KW - Atrial fibrillation

KW - Metformin

KW - Sub-clinical hyperthyroidism

UR - http://www.scopus.com/inward/record.url?scp=84899646067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899646067&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 252

EP - 258

JO - Hormones

JF - Hormones

SN - 1109-3099

IS - 2

ER -